GERD Clinical Trial
Official title:
Vented Base Feeding Bottle in Preterm Infants With GERD Symptoms: Effects on Respiration-swallow Patterns and Reflux.
Aim of the study is to evaluate the effects of vented base bottles on respiration-swallow
patterns and on gastroesophageal refluxes in preterm infants with clinical suspect of
gastroesophageal reflux disease (GERD).
In this crossover-randomized study, we compared the effects of standard feeding bottles (A)
versus vented base feeding bottles (B) on a group of patients with at least 2 clinical GERD
symptoms. 24 hours of synchronized cardiorespiratory (CR) and Esophageal Multichannel
intraluminal impedance (MII/pH) monitoring were evaluated for each patient. During this
period, patients were fed alternatively with feeding bottle A and B.
In preterm infants a deficit of both coordination and gastro-intestinal motility is often the
underpinning cause of oxygen desaturations and gastro-esophageal reflux. Breastfeeding
enhances the maturation of the respiration-swallow mechanism. For this reason, a feeding
bottle that best recreates the physiological sucking from the maternal breast is highly
desirable in non-breastfed newborns.
Population: newborns referred to esophageal Multichannel Intraluminal Impedance and pH-metry
(MII/pH) combined with cardiorespiratory (CR) monitoring for GERD or cardio-respiratory
symptoms
Materials and methods: we compare the effects of traditional feeding bottles (A) versus
vented base feeding bottles (B) on cardiorespiratory and reflux events in newborns undergoing
24 hours synchronized CR and MII/pH monitoring. During the exam, newborns are fed,
alternatively, by feeding bottle A and B with human milk or formula. Some training meals are
offered the day before monitoring to get newborns enrolled into the study used to vented base
feeding bottles.
Cardiorespiratory monitoring is performed through VitaGuard VG3100® (Getemed Medizin- und
Informationstechnik AG, Teltow, Germany) based on Masimo Signal Extraction Technology (SET)®
(Masimo Corp., Irvine, CA, USA). It operates with a blood oxygen saturation (SpO2) detector,
placed on the right wrist, and 3 thoracic electrodes. This instrument is able to record ECG,
heart rate, SpO2 and thoracic plethysmographic curve. The signals are analyzed with VitaWin
3® software (Getemed Medizin - und Informationstechnik AG, Teltow, Germany), by filtering
artifacts.
The MII/pH monitoring is performed through a neonatal catheter (Infant Comfort TEC®) with 7
impedence electrodes (creating 6 impedance channels) and one pH detector able to cover the
whole distance from the pharynx to the lower esophageal sphincter (LES) (channel 1). The pH
detector is placed within channel 1, 1.5 cm above the LES. The correct positioning of the
catheter is measured through fluoroscopy and eventually corrected. Data obtained from
impedance channels that result proximal to the superior esophageal sphincter are excluded
from the analysis. The acquisition and recording of MII/pH data are performed through Sleuth
System, Sandhill Scientific Inc., Highlands Ranch, Colorado, USA. The analysis of MII/pH
tracings is made visually by a single operator using BioView 5.3.4 software (Sleuth System,
Sandhill Scientific Inc., Highlands Ranch, Colorado, USA).
The variables analyzed are listed as follows:
Clinical variables:
- feeding time (min)
- feeding total volume (mL)
- n. GER during feeding
- n. GER in the post-prandial period (150 min after feeding)
Cardiorespiratory variables:
- frequency of apnea, desaturation and bradycardia during feeding
- frequency of apnea, desaturation and bradycardia during post-prandial period
- mean duration of apnea during feeding and post-prandial period
- mean and minimum desaturation level during feeding and post-prandial period
- mean and minimum heart rate during feeding and post-prandial period
MII/pH variables:
- Swallow frequency during feeding and post-prandial period (events/h)
- Bolus Presence Time (BPT): seconds between bolus entry and bolus exit in the distal
channel
- Bolus Head Advancing Time (BHAT): seconds between bolus entry in proximal channel and
entry in distal channel
- Bolus Head Advancing Time Corrected for Esophageal Length (BHATc): BHAT corrected for
esophageal length (BHATc = BHAT / esophageal length)
- Reflux pH: minimum pH value registered during each GER event. It classifies refluxes
into 3 different types: acid (pH < 4), weakly acid (pH 4-7) and weakly alkaline (pH > 7)
- GER frequency, (events/h)
- Bolus Clearance Time (BCT): reflux duration, recorded at distal channel (s)
- Bolus Reflux Extent (BRE), (n. channels)
- Proximal GER frequency (events/h)
- Bolus Exposure Index (BEI): percentage of time in which GER involves esophagus during
MII/pH monitoring
- Reflux Index (RI): percentage of time during which pH falls below 4 during MII/pH
monitoring
Randomization: the alternate use of feeding bottles A and B is set by a binary random
sequencing generated by Microsoft Office Excel software that indicates the first feeding
bottle to be used. This is a single-blind study since the sequence is unknown to the
specialist in charge of reporting MII/pH and CR monitoring.
Statistical analysis:
The analysis is made with Statistical Software Package For Windows® (StatSoft, Inc., Tulsa,
Oklahoma, USA). Kolmogorov-Smirnov test and exploratory data analysis are used to define
normality range. Data will be expressed as mean and standard deviation (SD), or as median and
interquartile range if more appropriate. Differences among cardiorespiratory and MII/pH
variables will be evaluated with Student paired T test or Wilcoxon test if more appropriate.
Significance will be considered as p<0.05.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06084572 -
Prospective Evaluation of pH-impedance Tracings According to the Wingate Consensus, and Influence on GERD Classification According to the Lyon Consensus
|
||
Completed |
NCT03568825 -
Response Surface Pathway Design With Two Interventional- and One Response Variable in Estimating Minimum Efficacy Dose
|
N/A | |
Recruiting |
NCT04703374 -
A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04120025 -
Effectiveness of Diaphragmatic Breathing on Reflux Symptoms in Outpatients
|
N/A | |
Withdrawn |
NCT04771247 -
Endoscopic Cardiac Band Ligation for the Management of Refractory GERD After Laparoscopic Sleeve Gastrectomy
|
N/A | |
Completed |
NCT02575287 -
Minimal Injuries From Esophagus Detected by Optical Enhancement Systemâ„¢ Associated to Optical Magnification HD Scopes
|
N/A | |
Completed |
NCT01710800 -
Twenty-Four Hour Combined Multi-Channel Impedance and pH Ambulatory Monitoring: Impedance Reflux Episodes of Patients On and Off Proton Pump Inhibitor Therapy
|
N/A | |
Completed |
NCT00287339 -
The Utility of Nexium in Chronic Cough and Reflux Disease
|
Phase 4 | |
Completed |
NCT00287391 -
Sleep Disorders and Gastroesophageal Reflux Disease (GERD)
|
Phase 4 | |
Completed |
NCT00629564 -
An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)
|
Phase 4 | |
Completed |
NCT04243668 -
ANTI REFLUX MUCOSAL ABLATION THERAPHY (ARMA)
|
N/A | |
Completed |
NCT03558477 -
PK/PD Clinical Trial of YYD601 in Healthy Adult Male
|
Phase 1 | |
Recruiting |
NCT05042063 -
Acoustic Cough Monitoring for the Management of Patients With Known Respiratory Disease
|
||
Completed |
NCT05069493 -
Long-term Follow-up After Hiatal Hernia Repair by Tension-free Mesh Closure or Simple Suturing
|
||
Terminated |
NCT04626232 -
Comparison of the Sleeve Gastrectomy Technique With a Nissen Fundoplication Added to the Conventional Sleeve Gastrectomy Technique in Morbidly Obese Patients
|
N/A | |
Completed |
NCT03238534 -
Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS
|
Phase 4 | |
Recruiting |
NCT05974722 -
Mesh Vs Pledgets for Repair of Paraesophageal Hernia
|
N/A | |
Recruiting |
NCT05781347 -
Stretta Versus Conservative Treatment in Obese and Non-obese
|
N/A | |
Completed |
NCT06141577 -
A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT05108038 -
A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects
|
Phase 1 |